BD SpectralFX™ Technology maximizes the number of colors that can be used in flow cytometry, allowing scientists to analyze up to 50 or more characteristics of a single cell at one time, with optimal ...

Continue ReadingPiramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, in conjunction with the 2025 SelectUSA Investment Summit, commits to a $90M investment ...

CPR Therapeutics Inc. is an early-stage start-up supported by funding from the NSF and NIH CPR Therapeutics Inc. announced today that the company has received a continuation U.S. patent for technology ...

Da Vinci 5 is the newest entry to the da Vinci portfolio of systems, which also includes da Vinci X®, da Vinci Xi®, and da Vinci SP®. The system can be used for minimally invasive surgical procedures ...

The field of orthodontics is undergoing a transformation, with a growing emphasis on personalized care. This shift is driven by the need to tailor treatment plans to individual patients, ensuring… ...

When it comes to overcoming addiction, the environment in which one seeks treatment can significantly impact their recovery journey. Luxury residential treatment programs offer a unique blend of ...

Preserving natural teeth is essential as they play a vital role in chewing, speaking, and maintaining jaw and facial structure.

This collaboration aims to extract and validate a range of AI-based quantitative CT (QCT) measures, identifying imaging biomarkers that hold the greatest potential for improving COPD phenotyping and ...

Medical diagnostics is undergoing a rapid transformation, and United Imaging is at the forefront of this change. Through a combination of advanced technology, artificial intelligence and thoughtful ...

Continue ReadingTrogenix Further Strengthens its Scientific Advisory Board with the Appointment of World-Leading Experts, Prof Nada Jabado and Prof Burkhard Becher ...

The investment is aimed at supporting the company's strategy to deliver its platform and product suite to global pharma companies through a SaaS model, while continuing to invest in further offerings ...